These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29687658)

  • 1. Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus.
    Yozgatli K; Lefrandt JD; Noordzij MJ; Oomen PHN; Brouwer T; Jager J; Castro Cabezas M; Smit AJ
    Diabet Med; 2018 Apr; ():. PubMed ID: 29687658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
    Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
    Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study.
    Blanc-Bisson C; Velayoudom-Cephise FL; Cougnard-Gregoire A; Helmer C; Rajaobelina K; Delcourt C; Alexandre L; Blanco L; Mohammedi K; Monlun M; Rigalleau V
    Cardiovasc Diabetol; 2018 Jun; 17(1):82. PubMed ID: 29884175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis.
    Hosseini MS; Razavi Z; Ehsani AH; Firooz A; Afazeli S
    EClinicalMedicine; 2021 Dec; 42():101194. PubMed ID: 34841236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
    Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
    Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
    Alkhami F; Borderie G; Foussard N; Larroumet A; Blanco L; Barbet-Massin MA; Ferriere A; Ducos C; Mohammedi K; Fawaz S; Couffinhal T; Rigalleau V
    Diabetes Metab; 2024 Mar; 50(2):101524. PubMed ID: 38346471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
    Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
    Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin advanced glycation end products in HIV infection are increased and predictive of development of cardiovascular events.
    Sprenger HG; Bierman WF; Martes MI; Graaff R; van der Werf TS; Smit AJ
    AIDS; 2017 Jan; 31(2):241-246. PubMed ID: 27763891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.
    Bos DC; de Ranitz-Greven WL; de Valk HW
    Diabetes Technol Ther; 2011 Jul; 13(7):773-9. PubMed ID: 21510765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Self-reported Physical Activity and Skin Autofluorescence, a Marker of Tissue Accumulation of Advanced Glycation End Products in Adults With Type 1 Diabetes: A Cross-sectional Study.
    Duda-Sobczak A; Falkowski B; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Clin Ther; 2018 Jun; 40(6):872-880. PubMed ID: 29567299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study.
    Diallo AM; Jaisson S; Barriquand R; Lukas C; Barraud S; Decoudier B; Francois M; Ly S; Mahmoudi R; Arndt C; Nazeyrollas P; Gillery P; Delemer B
    Diabetes Ther; 2022 Aug; 13(8):1531-1546. PubMed ID: 35779209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes.
    Araszkiewicz A; Naskret D; Niedzwiecki P; Samborski P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
    Diabetes Technol Ther; 2011 Aug; 13(8):837-42. PubMed ID: 21568748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications.
    Sjöström L; Peltonen M; Jacobson P; Ahlin S; Andersson-Assarsson J; Anveden Å; Bouchard C; Carlsson B; Karason K; Lönroth H; Näslund I; Sjöström E; Taube M; Wedel H; Svensson PA; Sjöholm K; Carlsson LM
    JAMA; 2014 Jun; 311(22):2297-304. PubMed ID: 24915261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study.
    van Wijngaarden RPT; Overbeek JA; Heintjes EM; Schubert A; Diels J; Straatman H; Steyerberg EW; Herings RMC
    Diabetes Ther; 2017 Oct; 8(5):1097-1109. PubMed ID: 28921256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus.
    Johnson BL; Blackhurst DW; Latham BB; Cull DL; Bour ES; Oliver TL; Williams B; Taylor SM; Scott JD
    J Am Coll Surg; 2013 Apr; 216(4):545-56; discussion 556-8. PubMed ID: 23391591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring of Advanced Glycation End Products in Acute Stroke Care: Skin Autofluorescence as a Predictor of Ischemic Stroke Outcome in Patients with Diabetes Mellitus.
    Filipov A; Fuchshuber H; Kraus J; Ebert AD; Sandikci V; Alonso A
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
    de Vos LC; Noordzij MJ; Mulder DJ; Smit AJ; Lutgers HL; Dullaart RP; Kamphuisen PW; Zeebregts CJ; Lefrandt JD
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):131-8. PubMed ID: 23139292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
    Škrha J; Horová E; Šoupal J; Valeriánová A; Malík J; Prázný M; Zima T; Kalousová M; Škrha J
    J Diabetes Complications; 2022 Jul; 36(7):108206. PubMed ID: 35644724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between skin autofluorescence and vascular complications in Chinese patients with diabetic foot ulcer: an observational study done in Shanghai.
    Liu C; Xu L; Gao H; Ye J; Huang Y; Wu M; Xie T; Ni P; Yu X; Cao Y; Lu S
    Int J Low Extrem Wounds; 2015 Mar; 14(1):28-36. PubMed ID: 25694437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.